{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:18:48Z","timestamp":1775737128749,"version":"3.50.1"},"reference-count":15,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"DOI":"10.2340\/actadv.v106.43695","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:40:00Z","timestamp":1775734800000},"page":"adv43695","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Inflammatory Indexes as Easy-to-Use Markers for Monitoring Psoriasis and Hidradenitis Suppurativa"],"prefix":"10.2340","volume":"106","author":[{"given":"Eugenia Veronica","family":"Di Brizzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Buononato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso Luca","family":"Falco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Fulgione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Caccavale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Argenziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Balato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"148206","doi-asserted-by":"crossref","unstructured":"Ziehfreund S, Wecker H, Mittag S, Weis J, Tizek L,Verkhoturova V, et al. Happiness across the borders: a cross-sectional study among patients with psoriasis and atopic dermatitis in Europe. J Eur Acad Dermatol Venereol 2025; 39: 529\u2013542","DOI":"10.1111\/jdv.20288"},{"key":"148207","doi-asserted-by":"crossref","unstructured":"Licata G, Di Brizzi EV, Castelli F, Giuffrida G, Stroppiana E, Dattola A, et al. Tildrakizumab and quality of life: deep dive into the impact of psoriasis and treatment on different domains: should psychosocial life impairment be -considered a comorbidity? J Clin Med 2025; 14: 223","DOI":"10.3390\/jcm14010223"},{"key":"148208","doi-asserted-by":"crossref","unstructured":"Zouboulis CC, Del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GB. Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 2015; 231: 184\u2013190","DOI":"10.1159\/000431175"},{"key":"148209","doi-asserted-by":"crossref","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133: 377\u2013385","DOI":"10.1038\/jid.2012.339"},{"key":"148210","doi-asserted-by":"crossref","unstructured":"Di Brizzi EV, Buononato D, Benvenuto P, et al. Effectiveness and safety after a switch to tildrakizumab: a real world multicenter Italian study in psoriasis. Dermatol Pract Concept 2023; 13: e2023215","DOI":"10.5826\/dpc.1304a215"},{"key":"148211","doi-asserted-by":"crossref","unstructured":"Mattei PL, Corey KC, Kimball AB. Psoriasis Area Severity -Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol 2014; 28: 333\u2013337","DOI":"10.1111\/jdv.12106"},{"key":"148212","doi-asserted-by":"crossref","unstructured":"Morariu SH, Cotoi OS, Tiuc\u0103 OM, Baican A, Gheuc\u0103-Solov\u0103stru L, Decean H, et al. Blood-count-derived inflammatory markers as predictors of response to biologics and small-molecule inhibitors in psoriasis: a multicenter study. J Clin Med 2024; 13: 3992","DOI":"10.3390\/jcm13143992"},{"key":"148213","doi-asserted-by":"crossref","unstructured":"Ding Q, Li X, Lin L, Xie X, Jing W, Chen X, et al. Association between systemic immunity-inflammation index and psoriasis among outpatient US adults. Front Immunol 2024; 15: 1368727","DOI":"10.3389\/fimmu.2024.1368727"},{"key":"148214","unstructured":"Satis S. New Inflammatory marker associated with disease activity in rheumatoid arthritis: the systemic immune-inflammation index. Curr Health Sci J 2021; 47: 553\u2013557."},{"key":"148215","unstructured":"Utlu Z. Evaluation of systemic immune and inflammatory biomarkers in hidradenitis suppurativa. Eur Rev Med Pharmacol Sci 2023; 27: 9267\u20139272."},{"key":"148216","doi-asserted-by":"crossref","unstructured":"Tiuc\u0103 OM, Morariu SH, Mariean CR, Tiuc\u0103 RA, Nicolescu AC, Cotoi OS. Impact of blood-count-derived inflammatory markers in psoriatic disease progression. Life (Basel) 2024; 14: 114","DOI":"10.3390\/life14010114"},{"key":"148217","doi-asserted-by":"crossref","unstructured":"Kulakli S, Oguz ID, Aksan B. Could blood cell-based -inflammatory markers be used to monitor response to biologic therapy in psoriasis? Sisli Etfal Hastan Tip Bul 2023; 57: 536\u2013542","DOI":"10.14744\/SEMB.2023.43569"},{"key":"148218","doi-asserted-by":"crossref","unstructured":"Hayran Y, \u015een O, Akta\u015f A. Systemic Immune-Inflammation Index (SII) correlates with disease severity in hidradenitis suppurativa patients. Indian J Dermatol 2023; 68: 208\u2013209","DOI":"10.4103\/ijd.ijd_532_22"},{"key":"148219","doi-asserted-by":"crossref","unstructured":"Kearney N, McCourt C, Hughes R, Alsharqi A, O\u2019Kane D, Kirby B. Systemic immune inflammation index is a -marker of cardiovascular risk and not just disease -severity in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2022; 36: e928\u2013e929","DOI":"10.1111\/jdv.18322"},{"key":"148220","doi-asserted-by":"crossref","unstructured":"Zhao Y, Bai YP, Li LF. Association between systemic immune-inflammation index and psoriasis, psoriasis comorbidities, and all-cause mortality: a study based on NHANES. Immun Inflamm Dis 2024; 12: e70050","DOI":"10.1002\/iid3.70050"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/43695\/53460","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/43695\/53460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:40:10Z","timestamp":1775734810000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/43695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.43695","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}